PMC:6365940 / 7637-8238 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/6365940","sourcedb":"PMC","sourceid":"6365940","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6365940","text":"2.3 MTT assay\nCells were plated into 96-well plates at approximately 5000 cells/well, and then treated with different doses of drugs for 24 h. Cell viability was detected by MTT assay according to manufacturer's instruction. Cell viability = Atreated/Acontrol × 100%. SPSS statistical software was used to calculate the value of IC50. Resistant index (RI) = IC50 of gemcitabine-resistant pancreatic cancer cells/IC50 of pancreatic cancer cells. Reversal fold (RF) = IC50 of gemcitabine in the absence of digoxin/IC50 of gemcitabine in the presence of digoxin. All assays were performed in triplicate.","divisions":[{"label":"label","span":{"begin":0,"end":3}},{"label":"title","span":{"begin":5,"end":14}}],"tracks":[]}